Schneider; Dina

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schneider; Dina.The latest application filed is for "compositions and methods for treating cancer with duocars".

Company Profile

34.20.36

Schneider; Dina - Potomac MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for treating cancer with DuoCARs Grant 11,453,712 - Orentas , et al. September 27, 2	2022-09-27
Compositions and methods for treating cancer with anti-ROR1 immunotherapy Grant 11,453,719 - Orentas , et al. September 27, 2	2022-09-27
Compositions and Methods for Treating Cancer with DuoCARs App 20220281946 - Orentas; Rimas J. ; et al.	2022-09-08
Compositions and Methods for Treating Cancer with DuoCARs App 20220169698 - Orentas; Rimas J. ; et al.	2022-06-02
Compositions And Methods For Treating Cancer With Self-driving Chimeric Antigen Receptors App 20220168344 - Schneider; Dina ; et al.	2022-06-02
Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy Grant 11,242,389 - Schneider , et al. February 8, 2	2022-02-08
Compositions and methods for treating cancer with DuoCARs Grant 11,208,455 - Orentas , et al. December 28, 2	2021-12-28
Compositions and Methods for Treating Cancer with TSLPR-CD19 or TSLPR-CD22 Immunotherapy App 20210379110 - Schneider; Dina ; et al.	2021-12-09
Compositions And Methods For Treating Cancer With Anti-bcma Immunotherapy App 20210361709 - Schneider; Dina ; et al.	2021-11-25
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy App 20210353675 - Schneider; Dina ; et al.	2021-11-18
Compositions and methods for treating cancer with anti-CD38 immunotherapy Grant 11,103,533 - Schneider , et al. August 31, 2	2021-08-31
Compositions And Methods For Treating Hiv/aids With Immunotherapy App 20210206839 - Gonda; Kim Anthony ; et al.	2021-07-08
Compositions and methods for treating cancer with anti-BCMA immunotherapy Grant 11,052,112 - Schneider , et al. July 6, 2	2021-07-06
Compositions and methods for treating cancer with anti-CD38 immunotherapy Grant 11,045,497 - Schneider , et al. June 29, 2	2021-06-29
Compositions and Methods for Treating Cancer with Anti-CD19/CD22 Immunotherapy App 20210171632 - Schneider; Dina ; et al.	2021-06-10
Compositions and Methods for Treating Cancer with Anti-CD19/CD22 Immunotherapy App 20210171633 - Schneider; Dina ; et al.	2021-06-10
Compositions and Methods for Treating Cancer with Anti-CD123 Immunotherapy App 20210130479 - Orentas; Rimas J. ; et al.	2021-05-06
Compositions and methods for treating HIV/AIDS with immunotherapy Grant 10,894,819 - Gonda , et al. January 19, 2	2021-01-19
Compositions and Methods for Treating Cancer with DuoCARs App 20200392200 - Orentas; Rimas J. ; et al.	2020-12-17
Compositions and methods for treating cancer with anti-CD123 immunotherapy Grant 10,844,128 - Orentas , et al. November 24, 2	2020-11-24
Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy Grant 10,822,412 - Schneider , et al. November 3, 2	2020-11-03
Method to Treat Cancer with Engineered T-Cells App 20200297769 - Dropulic; Boro ; et al.	2020-09-24
Compositions And Methods For Treating Cancer With Anti-bcma Immunotherapy App 20200289572 - Schneider; Dina ; et al.	2020-09-17
Compositions and Methods for Treating Cancer with DuoCARs App 20200231648 - Orentas; Rimas J. ; et al.	2020-07-23
Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy App 20200231663 - Orentas; Rimas ; et al.	2020-07-23
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy App 20200197440 - Schneider; Dina ; et al.	2020-06-25
Compositions and methods for treating cancer with DuoCARs Grant 10,689,431 - Orentas , et al.	2020-06-23
Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy App 20200155661 - Orentas; Rimas J. ; et al.	2020-05-21
Method to treat cancer with engineered T-cells Grant 10,639,329 - Dropulic , et al.	2020-05-05
Compositions and Methods for Treating Cancer with Anti-CD19 Immunotherapy App 20200123254 - Schneider; Dina ; et al.	2020-04-23
Compositions And Methods For Treating Cancer With Anti-cd19/cd20 Immunotherapy App 20200109210 - Orentas; Rimas J. ; et al.	2020-04-09
Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy App 20200102385 - Orentas; Rimas J. ; et al.	2020-04-02
Compositions and Methods for Treating Cancer with Anti-CD33 Immunotherapy App 20200101109 - Orentas; Rimas ; et al.	2020-04-02
Compositions and Methods for Treating Cancer with Anti-CD19/CD22 Immunotherapy App 20200087396 - Schneider; Dina ; et al.	2020-03-19
Chimeric Antigen Receptors and Methods of Use App 20200079849 - Orentas; Rimas ; et al.	2020-03-12
Compositions and methods for treating cancer with anti-mesothelin immunotherapy Grant 10,550,179 - Orentas , et al. Fe	2020-02-04
Compositions and methods for treating cancer with anti-CD22 immunotherapy Grant 10,543,263 - Orentas , et al. Ja	2020-01-28
Compositions and Methods for Treating Cancer with Anti-CD123 Immunotherapy App 20200010555 - Orentas; Rimas J. ; et al.	2020-01-09
Compositions and methods for treating cancer with anti-CD19 immunotherapy Grant 10,501,539 - Schneider , et al. Dec	2019-12-10
Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy Grant 10,442,867 - Orentas , et al. Oc	2019-10-15
Compositions and methods for treating cancer with anti-ROR1 immunotherapy Grant 10,428,141 - Orentas , et al. October 1, 2	2019-10-01
Compositions and methods for treating cancer with anti-CD33 immunotherapy Grant 10,426,797 - Orentas , et al. October 1, 2	2019-10-01
Chimeric antigen receptors and methods of use Grant 10,421,810 - Orentas , et al. Sept	2019-09-24
Compositions and Methods for Treating Cancer with DuoCARs App 20190241641 - Orentas; Rimas ; et al.	2019-08-08
Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy App 20190218280 - Orentas; Rimas J. ; et al.	2019-07-18
Compositions And Methods For Treating Hiv/aids With Immunotherapy App 20190202895 - Gonda; Kim Anthony ; et al.	2019-07-04
Method to Treat Cancer with Engineered T-Cells App 20190134091 - Dropulic; Boro ; et al.	2019-05-09
Compositions and Methods For Treating Cancer With Anti-CD19 Immunotherapy App 20190106492 - Schneider; Dina ; et al.	2019-04-11
Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy App 20190099476 - Orentas; Rimas J. ; et al.	2019-04-04
Compositions and Methods for Treating Cancer with DuoCARs App 20190083596 - Orentas; Rimas J. ; et al.	2019-03-21
Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy App 20190055309 - Orentas; Rimas J. ; et al.	2019-02-21
Compositions and methods for treating cancer with anti-mesothelin immunotherapy Grant 10,183,993 - Orentas , et al. Ja	2019-01-22
Compositions And Methods For Treating Cancer With Anti-cd19/cd20 Immunotherapy App 20180355052 - Orentas; Rimas J. ; et al.	2018-12-13
Chimeric Antigen Receptors and Methods of Use App 20180305452 - Orentas; Rimas ; et al.	2018-10-25
Compositions and Methods for Treating Cancer with Anti-CD33 Immunotherapy App 20180280438 - Orentas; Rimas ; et al.	2018-10-04
Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy App 20180208645 - Orentas; Rimas ; et al.	2018-07-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.